Amgen Inc. (AMGN)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 69.05
   
  • Change Today:
    $-0.05
  • 52 Week High: $71.64
  • 52 Week Low: $48.27
  • Currency: US Dollars
  • Shares Issued: 777.71m
  • Volume: 2,959,663
  • Market Cap: $53,701m
  • RiskGrade: 80
  • Beta: 0.63

Amgen Inc. Overview

Incorporated in 1980, Amgen is the world's largest biotechnology company engaged in the discovery, development, manufacture and marketing of human therapeutics based on advances in cellular and molecular biology. Amgen’s research and development programmes focus primarily on hematology, oncology, inflammation, neurology and metabolic disorders. In July 2002, the group acquired Immunex Corporation, a biopharmaceutical company dedicated to developing immune system science to protect human health.

1 Day Chart (25-05-2012)

6 Month Chart

Financials

Latest F'cast
Div Yield 0.8%
Div Cover 7.3
Op Mrgn 27.7%
ROCE 15.9%
Latest F'cast
P/E 17.0
PEG n/a
Pr/Revenue 3.4
Pr/Book 2.8
Latest F'cast
Revenue 3.5%
PBT -21.9%
EPS -15.6%
DPS n/a

Amgen Inc. Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 14,771.00 3,961.00 283.00¢ 16.4 n/a -20% n/a 0.0%
31-Dec-08 15,003.00 5,015.00 379.00¢ 15.2 0.4 +34% n/a 0.0%
31-Dec-09 14,642.00 5,204.00 453.00¢ 12.5 0.6 +20% n/a 0.0%
31-Dec-10 15,053.00 5,317.00 482.00¢ 11.4 1.9 +6% n/a 0.0%
31-Dec-11 15,582.00 4,150.00 407.00¢ 15.8 n/a -16% 56.00¢ 0.9%

Amgen Inc. Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 16,371.48 5,641.96 616.05¢ 11.2 0.2 +51% 133.56¢ 1.9%
31-Dec-13 16,923.28 6,077.48 678.82¢ 10.2 1.0 +10% 168.00¢ 2.4%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Amgen Inc. ShareCast News

Astra to back Amgen development 03-Apr-2012 ShareCast
US broker round-up 06-Mar-2012 ShareCast
US close: Stocks fall as Greek talks drag on 06-Feb-2012 ShareCast

Amgen Inc. Top Newspaper Links

SEP cashes in as US giant Amgen buys cancer drug... 26-Jan-2011 The Scotsman
Amgen Buys a Cancer Drug Maker 25-Jan-2011 New York Times
Tech Ticker 16-Dec-2010 BayArea.com

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 69.05
Change Today $ -0.05
% Change -0.07 %
52 Week High $71.64
52 Week Low $48.27
Volume 2,959,663
Shares Issued 777.71m
Market Cap $53,701m
Beta 0.63
RiskGrade 80

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 16
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-May-2012

Time Volume / Share Price
16:00 2,870 @ $69.05
16:00 297 @ $69.05
16:00 1,393 @ $69.05
15:59 100 @ $69.02
15:59 100 @ $69.02

Top of Page